CClinicalTrials.gg
CompletedNCT01796509SUIVI-REAUpdated Jan 5, 2022

Study in Intensive Care Follow-up Programme in Improving Long-term Outcomes of ICU Survivors

An interventional study of Medical, psychological, social in Quality of Life and Post ICU Discharge, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-01-05.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
545
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Study Hypothesis:

Critical illness is associated with long-term medical and psychological sequelae that can impact the professional and private life. The purpose of the present multicenter randomized controlled trial is to assess whether or not a medical, psychological and social follow-up improves quality of life of critically ill patients at one year after their discharge from intensive care unit (ICU).

Primary Purpose:

Death or severe alteration of quality of life assessed with help of EQ5D questionnaire at one year after ICU discharge.

Read the detailed description

Critically ill patients who had required at least 3 days of mechanical ventilation and who consented to participate will be randomized at time of ICU discharge in either follow-up or not follow-up arm. The medical, psychological and social follow-up consists of multidisciplinary consultation at time of ICU discharge (i.e. inclusion), at three, six and 12 months afterward. Patients of the "non follow-up group" will be seen only at one year. Medical consultation will be focused on evaluation of pre-existing co-morbidities, detection of new ones and of physical disorders related to critical illness (i.e. ICU-acquired paresis, pain, functional disability, cognitive dysfunction...). Psychological assessment will be focused on detection of anxiety, depression and post-traumatic stress syndrome. Social follow-up will assess the social need of the patient in the professional and private domains. Each assessment will be standardized by using validated or appropriate scores. At the end of each multidisciplinary consultation, a report will be sent to the patient and his general practitioner. When necessary, a consultation with a specialist will be organized. At one year, an observer blinded from randomization will call all the patients to assess their quality of life with help of EQ5D questionnaire. Economical cost of multidisciplinary follow-up will be assessed.

To our knowledge, there is no follow-up studies that have combined a medical, psychological and social cares. For instance, the PracTical study has not evidenced an improvement of quality of life in patients who had beneficiated from nurse consultations at 3 and 9 months.

02

Conditions studied

  • Quality of Life
  • Post ICU Discharge

Keywords

  • Quality of life,
  • Sequela disorders,
  • Socio-professional impact,
  • Anxiety, depression,
  • Post traumatic stress disorder,
  • ICU acquired paresis.
03

In context

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Men and women older than 18
  • Living in an area near the hospital
  • Hospitalized in the ICU medical surgical hospitals in this study.
  • Who required mechanical ventilation more than 3 days
  • Having a life expectancy greater than one year (Mc Cabe score >2, absence of metastatic cancer)
  • Having a general practitioner identified
  • Is affiliated to a social health care
  • And who have given their written informed consent

Exclusion criteria

Exclusion Criteria:

  • Patients hospitalized in ICU in the previous year
  • Patients followed for a preexisting myopathy
  • The burn patients, patients with brain injury (Glasgow initial \<8) or trauma
  • Patients hospitalized for suicide or self-induced poisoning
  • Patients with psychiatric disorders
  • Patients with ore dementia
  • Pregnant women
  • Patients who do not speak fluently French
  • Patients with guardianship
  • Homeless patients
  • No having a general practitioner identified
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
545 participants (actual)

Study arms

  • Experimental
    multidisciplinary follow-up

    Other: Medical, psychological, social

  • No intervention
    no follow-up

Interventions

  • OtherMedical, psychological, social

    After having given his consent, the patient filled auto questionnaire, and then randomized either in follow up arm (i.e. intervention group) or in no follow up arm (i.e. control group). In the follow up arm, medical, psychological and social consultation will be planned within the first seven days after inclusion, and then 3, 6, 12 months. During medical consultation a general examination will be performed, muscle strength, cognitive function, functional disabilities will be assessed with help of MRC, MMS. During psychological consultation, anxiety and depression will be assessed with the help of HAD, IES. The psychologist will also have a free interview. During social consultation personal and professional reinsertion will be assessed.

06

What researchers measure

Primary outcomes

  1. Death or severe alteration of quality of life assessed after ICU discharge

    Death or severe alteration of quality of life assessed with help of EQ5D questionnaire at one year after ICU discharge.

    Time frame: 1 year

Secondary outcomes

  1. Assessment of life quality in Medical domain

    ICU-acquired paresis assessed with help of MRC sum score, Functional disabilities assessed with help of Barthel and IADL scales, Cognitive dysfunctions assessed with help of MMS score, Pain, Comorbidities (Hypertension, etc...).

    Time frame: 1 year

  2. Assessment in psychological domain

    Anxiety assessed with help of HAD scale, Depression assessed with help of HAD scale Post-traumatic stress syndrome assessed with help of IES scale.

    Time frame: 1 year

  3. Assessment in social domain

    Social reinsertion with help of RNLI scale.

    Time frame: 1 year

  4. Assessment in economical cost

    Number of hospitalization,number of outpatient consultation and prescription of new treatment will be assessed within 1 year.

    Time frame: 1 year

07

Study locations

1 site
  • Hôpital Raymond Poincaré
    Garches, Ile De France 92380, France
08

References and documents

Publications

  • Friedman D, Grimaldi L, Cariou A, Aegerter P, Gaudry S, Ben Salah A, Oueslati H, Megarbane B, Meunier-Beillard N, Quenot JP, Schwebel C, Jacob L, Robin Lagandre S, Kalfon P, Sonneville R, Siami S, Mazeraud A, Sharshar T. Impact of a Postintensive Care Unit Multidisciplinary Follow-up on the Quality of Life (SUIVI-REA): Protocol for a Multicenter Randomized Controlled Trial. JMIR Res Protoc. 2022 May 9;11(5):e30496. doi: 10.2196/30496. Erratum In: JMIR Res Protoc. 2023 Apr 14;12:e47929. doi: 10.2196/47929. PubMed 35532996 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01796509
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Responsible party
Sponsor
First posted
Feb 21, 2013
Start date
Dec 2012
Primary completion
Sep 2018
Completion
Mar 11, 2020
Last update
Jan 5, 2022

Study contacts

Tarek Sharshar, MD, PHD
study director · ICU, Hôpital Raymond Poincaré
Diane Friedman, MD
principal investigator · ICU, Hôpital Raymond Poincaré

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion